Mehta Kishan
Insider CIK 1850520 · BHVN Director · BNTC Director · DNAA Director, 10% owner · DNAC Director, 10% owner · DNAB Director, 10% owner · DNAD Director, 10% owner · BHVN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BHVN Biohaven Ltd. | A Award deriv | 2026-04-28 | 2026-04-30 | 68,693 | — | $0 | 68,693 | SEC↗ |
| BHVN Biohaven Ltd. | G Gift | 2026-03-17 | 2026-03-19 | 17,342 | — | $0 | 17,342 | SEC↗ |
| BHVN Biohaven Ltd. | G Gift | 2026-03-17 | 2026-03-19 | 17,342 | — | $0 | 5,320 | SEC↗ |
| BNTC Benitec Biopharma Inc. | A Award deriv | 2025-12-01 | 2025-12-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2025-05-05 | 2025-05-07 | 31,716 | — | $0 | 31,716 | SEC↗ |
| BNTC Benitec Biopharma Inc. | A Award deriv | 2024-12-09 | 2024-12-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2024-04-30 | 2024-05-02 | 16,592 | — | $0 | 16,592 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2023-05-02 | 2023-05-04 | 52,906 | — | $0 | 52,906 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 8,239 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 13,004 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 15,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 20,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 1,875 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 6,502 | — | $0 | 6,502 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 4,119 | — | $0 | 4,119 | SEC↗ |
| BHVN Biohaven Ltd. | A Award deriv | 2022-10-03 | 2022-10-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 10,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 7,500 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 6,502 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise deriv | 2022-10-03 | 2022-10-05 | 4,119 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Ltd. | J Other deriv | 2022-10-03 | 2022-10-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer | 2022-10-03 | 2022-10-03 | 10,640 | $148.50 | $1.58M | 0 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 937 | — | $0 | 6,257 | SEC↗ |
| BHVN Biohaven Ltd. | F Tax w/h | 2022-10-03 | 2022-10-05 | 11,716 | $7.00 | $82.0K | 22,662 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 4,119 | $4.84 | $19.9K | 10,376 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 6,502 | $4.61 | $30.0K | 16,878 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 7,500 | $2.58 | $19.4K | 24,378 | SEC↗ |
| BHVN Biohaven Ltd. | M Exercise | 2022-10-03 | 2022-10-05 | 10,000 | $1.86 | $18.6K | 34,378 | SEC↗ |
| BHVN Biohaven Ltd. | J Other | 2022-10-03 | 2022-10-05 | 5,320 | — | $0 | 5,320 | SEC↗ |
| AKLI Akili, Inc. | M Exercise deriv | 2022-08-19 | 2022-08-23 | 6,220,000 | — | $0 | 0 | SEC↗ |
| AKLI Akili, Inc. | M Exercise | 2022-08-19 | 2022-08-23 | 6,220,000 | — | $0 | 6,860,000 | SEC↗ |
| AKLI Akili, Inc. | J Other | 2022-08-19 | 2022-08-23 | 6,860,000 | — | $0 | 0 | SEC↗ |
| PROK PROKIDNEY CORP. | M Exercise deriv | 2022-07-11 | 2022-07-13 | 6,220,000 | — | $0 | 0 | SEC↗ |
| PROK PROKIDNEY CORP. | M Exercise | 2022-07-11 | 2022-07-13 | 6,220,000 | — | $0 | 6,860,000 | SEC↗ |
| PROK PROKIDNEY CORP. | J Other | 2022-07-11 | 2022-07-13 | 6,860,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2022-04-28 | 2022-04-29 | 8,239 | — | $0 | 8,239 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-10 | 2022-01-12 | 1,875 | — | $0 | 1,875 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-10 | 2022-01-12 | 1,875 | — | $0 | 10,640 | SEC↗ |
| DNAA Social Capital Suvretta Ho | D To issuer deriv | 2021-08-16 | 2021-08-16 | 75,000 | — | $0 | 6,220,000 | SEC↗ |
| DNAB Social Capital Suvretta Ho | D To issuer deriv | 2021-08-16 | 2021-08-16 | 75,000 | — | $0 | 6,220,000 | SEC↗ |
| DNAC Social Capital Suvretta Ho | D To issuer deriv | 2021-08-16 | 2021-08-16 | 75,000 | — | $0 | 6,220,000 | SEC↗ |
| DNAD Social Capital Suvretta Ho | D To issuer deriv | 2021-08-16 | 2021-08-16 | 75,000 | — | $0 | 6,220,000 | SEC↗ |
| DNAA Social Capital Suvretta Ho | A Award | 2021-07-02 | 2021-07-07 | 640,000 | $10.00 | $6.40M | 640,000 | SEC↗ |
| DNAB Social Capital Suvretta Ho | A Award | 2021-07-02 | 2021-07-07 | 640,000 | $10.00 | $6.40M | 640,000 | SEC↗ |
| DNAC Social Capital Suvretta Ho | A Award | 2021-07-02 | 2021-07-07 | 640,000 | $10.00 | $6.40M | 640,000 | SEC↗ |
| DNAD Social Capital Suvretta Ho | A Award | 2021-07-02 | 2021-07-07 | 640,000 | $10.00 | $6.40M | 640,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2021-06-15 | 2021-06-17 | 13,004 | — | $0 | 13,004 | SEC↗ |